NEW ORLEANS — Ex vivo expanded stem cell allografts enhanced corneal stability with a low rejection rate in treating acute limbal stem cell deficiency, according to a surgeon speaking here.
Sheraz M. Daya, MD, speaking on behalf of colleague Omar J. Hakim, MD, presented the results of a study at the American Academy of Ophthalmology annual meeting.
Dr. Daya focused on early results of 10 procedures that he and colleagues published in Ophthalmology in 2005 and later findings on the same cases and a further 28 procedures. |